Galderma’s net sales top $4 billion in 2023 ahead of potential IPO
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Swiss dermatology company Galderma on Thursday said it generated more than $4 billion in net sales during 2023, up 8.5% on 2022 on a constant currency basis, driven by momentum across its dermatological skincare and injectable aesthetics products.
:max_bytes(150000):strip_icc():format(jpeg)/FPM-Best-Personal-Loans-Methodology-Recirc-468fcab5bfa84ae485bd56843cf5c0eb.png "How We Review and Rate Personal Loan Lenders")
:max_bytes(150000):strip_icc():format(jpeg)/PropertyValuation-4ecdfe3a87144fe998087ef433f49c13.jpeg "Is There a Gender Gap in Home Equity Loans?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1346781100-2724c28da6b2479b88db9d1337ebe926.jpg "Buy Now, Pay Later or Rent-to-Own: Which Is the Smarter Way to Pay for Purchases?")